Mandarino LJ - Search Results

1

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: mandarino lj. J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91. doi: 10.1210/jcem.87.6.8567. J Clin Endocrinol Metab. 2002. PMID: 12050251

2

Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.

Miyazaki Y, He H, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: mandarino lj. Diabetes. 2003 Aug;52(8):1943-50. doi: 10.2337/diabetes.52.8.1943. Diabetes. 2003. PMID: 12882909 Clinical Trial.

3

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: mandarino lj. J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9. doi: 10.1210/jc.2004-0190. J Clin Endocrinol Metab. 2004. PMID: 15356026 Clinical Trial.

4

Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes.

Pratipanawatr T, Cusi K, Ngo P, Pratipanawatr W, Mandarino LJ, DeFronzo RA. Pratipanawatr T, et al. Among authors: mandarino lj. Diabetes. 2002 Feb;51(2):462-8. doi: 10.2337/diabetes.51.2.462. Diabetes. 2002. PMID: 11812756

5

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: mandarino lj. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43. doi: 10.1152/ajpendo.0327.2001. Am J Physiol Endocrinol Metab. 2002. PMID: 12424102 Free article. Clinical Trial.

6

Synergistic interaction of magnesium and vanadate on glucose metabolism in diabetic rats.

Matsuda M, Mandarino L, DeFronzo RA. Matsuda M, et al. Metabolism. 1999 Jun;48(6):725-31. doi: 10.1016/s0026-0495(99)90171-3. Metabolism. 1999. PMID: 10381146

7

Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.

Iozzo P, Pratipanawatr T, Pijl H, Vogt C, Kumar V, Pipek R, Matsuda M, Mandarino LJ, Cusi KJ, DeFronzo RA. Iozzo P, et al. Among authors: mandarino lj. Am J Physiol Endocrinol Metab. 2001 May;280(5):E712-9. doi: 10.1152/ajpendo.2001.280.5.E712. Am J Physiol Endocrinol Metab. 2001. PMID: 11287353 Free article.

8

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: mandarino lj. Diabetes Care. 2001 Apr;24(4):710-9. doi: 10.2337/diacare.24.4.710. Diabetes Care. 2001. PMID: 11315836 Clinical Trial.

9

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

Miyazaki Y, Glass L, Triplitt C, Matsuda M, Cusi K, Mahankali A, Mahankali S, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: mandarino lj. Diabetologia. 2001 Dec;44(12):2210-9. doi: 10.1007/s001250100031. Diabetologia. 2001. PMID: 11793023 Clinical Trial.

10

Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects.

Lee NA, Matsuda M, Bressler P, Pratipanawatr T, Glass L, Mandarino LJ, DeFronzo RA. Lee NA, et al. Among authors: mandarino lj. Diabetes Obes Metab. 2002 May;4(3):195-200. doi: 10.1046/j.1463-1326.2002.00203.x. Diabetes Obes Metab. 2002. PMID: 12047398 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters